These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
366 related articles for article (PubMed ID: 35865470)
1. Drug Resistance Mechanisms of Acute Myeloid Leukemia Stem Cells. Niu J; Peng D; Liu L Front Oncol; 2022; 12():896426. PubMed ID: 35865470 [TBL] [Abstract][Full Text] [Related]
2. Leukemia stem cell-bone marrow microenvironment interplay in acute myeloid leukemia development. Yao Y; Li F; Huang J; Jin J; Wang H Exp Hematol Oncol; 2021 Jul; 10(1):39. PubMed ID: 34246314 [TBL] [Abstract][Full Text] [Related]
3. Cellular and Molecular State of Myeloid Leukemia Stem Cells. Xie X; Feng M; Wang Q; Wang J; Yin R; Li Y; Zhang H Adv Exp Med Biol; 2019; 1143():41-57. PubMed ID: 31338814 [TBL] [Abstract][Full Text] [Related]
4. The genesis and evolution of acute myeloid leukemia stem cells in the microenvironment: From biology to therapeutic targeting. Chen Y; Li J; Xu L; Găman MA; Zou Z Cell Death Discov; 2022 Sep; 8(1):397. PubMed ID: 36163119 [TBL] [Abstract][Full Text] [Related]
5. Therapeutic targeting of leukemia stem cells in acute myeloid leukemia. Barbosa K; Deshpande AJ Front Oncol; 2023; 13():1204895. PubMed ID: 37601659 [TBL] [Abstract][Full Text] [Related]
6. Escape From Treatment; the Different Faces of Leukemic Stem Cells and Therapy Resistance in Acute Myeloid Leukemia. van Gils N; Denkers F; Smit L Front Oncol; 2021; 11():659253. PubMed ID: 34012921 [TBL] [Abstract][Full Text] [Related]
7. CD9, a potential leukemia stem cell marker, regulates drug resistance and leukemia development in acute myeloid leukemia. Liu Y; Wang G; Zhang J; Chen X; Xu H; Heng G; Chen J; Zhao Y; Li J; Ni Y; Zhang Y; Shan J; Qian C Stem Cell Res Ther; 2021 Jan; 12(1):86. PubMed ID: 33494824 [TBL] [Abstract][Full Text] [Related]
9. Clinical roles of TIM-3 in myeloid malignancies and its importance in cellular therapy. Kikushige Y Blood Cell Ther; 2022 Dec; 5(Spec Edition):S1-S5. PubMed ID: 37220607 [TBL] [Abstract][Full Text] [Related]
10. Lipids and the cancer stemness regulatory system in acute myeloid leukemia. Lim INX; Nagree MS; Xie SZ Essays Biochem; 2022 Sep; 66(4):333-344. PubMed ID: 35996953 [TBL] [Abstract][Full Text] [Related]
12. Roles of the bone marrow niche in hematopoiesis, leukemogenesis, and chemotherapy resistance in acute myeloid leukemia. Wang A; Zhong H Hematology; 2018 Dec; 23(10):729-739. PubMed ID: 29902132 [TBL] [Abstract][Full Text] [Related]
13. Integrative single-cell expression and functional studies unravels a sensitization to cytarabine-based chemotherapy through HIF pathway inhibition in AML leukemia stem cells. Velasco-Hernandez T; Trincado JL; Vinyoles M; Closa A; Martínez-Moreno A; Gutiérrez-Agüera F; Molina O; Rodríguez-Cortez VC; Ximeno-Parpal P; Fernández-Fuentes N; Petazzi P; Beneyto-Calabuig S; Velten L; Romecin P; Casquero R; Abollo-Jiménez F; de la Guardia RD; Lorden P; Bataller A; Lapillonne H; Stam RW; Vives S; Torrebadell M; Fuster JL; Bueno C; Sarry JE; Eyras E; Heyn H; Menéndez P Hemasphere; 2024 Feb; 8(2):e45. PubMed ID: 38435427 [TBL] [Abstract][Full Text] [Related]
14. The biomarkers of leukemia stem cells in acute myeloid leukemia. Ding Y; Gao H; Zhang Q Stem Cell Investig; 2017; 4():19. PubMed ID: 28447034 [TBL] [Abstract][Full Text] [Related]
15. Characteristics of leukemic stem cells in acute leukemia and potential targeted therapies for their specific eradication. Hansen Q; Bachas C; Smit L; Cloos J Cancer Drug Resist; 2022; 5(2):344-367. PubMed ID: 35800375 [TBL] [Abstract][Full Text] [Related]